Alta Advisers’s AbbVie ABBV Stock Holding History

Alta Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.7M	Hold	6,765	–	–	0.39%	29
2026 Q1	$1.47M	Hold	6,765	–	–	0.53%	26
2025 Q4	$1.55M	Sell	6,765 -2,000	-23%	-$456K	0.56%	23
2025 Q3	$2.03M	Hold	8,765	–	–	0.62%	27
2025 Q2	$1.63M	Hold	8,765	–	–	0.58%	27
2025 Q1	$1.84M	Buy	8,765 +2,900	+49%	+$564K	0.78%	26
2024 Q4	$1.04M	Buy	5,865 +1,069	+22%	+$197K	0.66%	27
2024 Q3	$947K	Buy	4,796 +96	+2%	+$17.9K	0.43%	25
2024 Q2	$806K	Hold	4,700	–	–	0.39%	26
2024 Q1	$856K	Hold	4,700	–	–	0.42%	25
2023 Q4	$728K	Hold	4,700	–	–	0.39%	25
2023 Q3	$701K	Hold	4,700	–	–	0.41%	24
2023 Q2	$633K	Hold	4,700	–	–	0.36%	27
2023 Q1	$749K	Hold	4,700	–	–	0.45%	22
2022 Q4	$760K	Hold	4,700	–	–	0.46%	23
2022 Q3	$631K	Buy	+4,700	New	+$674K	0.4%	24

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alta Advisers's ABBV Position: Q2 2026 in Review

Alta Advisers held its AbbVie (ABBV) position steady in Q2 2026 at 6,765 shares worth $1.7M. The position accounts for 0.39% of the portfolio, ranked #29.

Alta Advisers first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.03M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Alta Advisers held 6,765 shares of AbbVie worth $1.7M as of Q2 2026.
Alta Advisers left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.39% of Alta Advisers's portfolio in Q2 2026, its #29 holding.
Alta Advisers first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
Alta Advisers's AbbVie position peaked at $2.03M in Q3 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alta Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.